OrbusNeich Medical Company Revenue
Medical Equipment Manufacturing • 
Units 303 & 305, 3/F, Hong Kong • 201-500 Employees
OrbusNeich Medical Company revenue & valuation
| Annual revenue | $153,900,000 |
| Revenue per employee | $723,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $492,400,000 |
| Total funding | $200,000,000 |
Key Contacts at OrbusNeich Medical Company
Jason Chen
Executive Director And Chief Financial Officer
Amanda Kellar
Us Sales Director
Michael Bernard
Sales Director
Cristiano Meneghin
Business Development Director Emea
Dennis Lai
Senior Director Of Sales Asia Pacific
Sangkeun Yeon
Director
Ken Choen Yip
Financial Director
Michael Giese
Senior Director Engineering
Genichiro Tanabe
Director,Sales&Marketing
Jasmine Lu
Director Of Regulatory Affairs, Asia Pacific
Company overview
| Headquarters | Units 303 & 305, 3/F, Building 20E, Hong Kong Science Park, 20 Science Park East Avenue, Shatin, New Territories, Hong Kong, HK |
| Phone number | +85228022288 |
| Website | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Interventional Cardiology, Coronary Interventions, Balloon Angioplasty, Cardiovascular Medical Device Manufacturer, Peripheral Interventions, Chronic Total Occlusion, Coronary Stents, Complex Pci |
| Founded | 2000 |
| Employees | 201-500 |
| Socials |
OrbusNeich Medical Company Email Formats
OrbusNeich Medical Company uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@orbusneich.com), used 56.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@orbusneich.com | 56.4% |
{first initial}{last name} | jdoe@orbusneich.com | 38.2% |
{2char} | {2char}@orbusneich.com | 2.7% |
{first name} | john@orbusneich.com | 1.8% |
About OrbusNeich Medical Company
OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. As of 30 June, 2025, OrbusNeich has more than 250 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies, including its Scoreflex NC product, the world’s smallest profile non-compliant scoring balloon; its proprietary “drug plus antibody” COMBO dual therapy stent; and its JADE non-compliant peripheral balloon, the first and only non-compliant over-the-wire PTA balloon approved by the FDA that is compatible with all guidewire systems in the U.S. OrbusNeich is listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”), under the stock code 6929. For more information and news, visit https://orbusneich.com/. (Last updated on 15 August 2025)
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
OrbusNeich Medical Company has 96 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore OrbusNeich Medical Company's funding history, including investment rounds, total capital raised, and key backers.
OrbusNeich Medical Company Tech Stack
Discover the technologies and tools that power OrbusNeich Medical Company's digital infrastructure, from frameworks to analytics platforms.
Security
Cookie compliance
JavaScript libraries
JavaScript libraries
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
SwitzerlandFrequently asked questions
4.8
40,000 users
